Aster Al Raffah Hospitals & Clinics, part of Aster DM Healthcare, has launched its second Walk Again Advanced Robotic Rehabilitation Centre in Sohar, Oman, expanding access to advanced neuro-rehabilitation services beyond Muscat.
The new centre features AI-powered robotic rehabilitation technologies to support recovery for patients with neurological and musculoskeletal conditions, including stroke, spinal cord injuries, cerebral palsy, multiple sclerosis, autism, Alzheimer‘s disease, and dementia. It also offers multidisciplinary care across neurology, spine, sports medicine, and mental wellbeing.
Dr. Azad Moopen, Founder Chairman of Aster DM Healthcare, highlighted the significance of the initiative, stating “The launch of our second Walk Again Advanced Robotic Rehabilitation reinforces our commitment to making advanced healthcare accessible across Oman. Expanding to Sohar ensures patients in northern regions benefit from world-class rehabilitation technologies closer to home. Through our Treat in Oman initiative, we continue reducing the need for overseas travel while strengthening Oman’s healthcare leadership.”
Click here to join our WhatsApp channel here
Ms. Alisha Moopen, Managing Director & Group CEO, added “At Aster, our mission is to combine innovation with compassionate care to transform outcomes. The Sohar centre brings advanced neuro-rehabilitation closer to patients who need it most, ensuring access to cutting-edge robotic technologies within their own communities. This reflects our commitment to building a more accessible and future-ready healthcare ecosystem in Oman.”
Dr. Sachin Kandhari, CEO of Walk Again India, remarked “The Sohar centre integrates globally recognized robotic rehabilitation systems with evidence-based protocols, enabling more precise and effective recovery for complex neurological conditions. We are proud to extend our collaboration with Aster and support Oman’s vision for advanced rehabilitation care.”
The facility supports Oman’s “Treat in Oman” initiative by bringing world-class rehabilitation closer to patients, reducing the need for overseas treatment, and strengthening the country’s medical tourism and healthcare innovation efforts.
Also read: HMC and Boehringer Ingelheim partner to advance clinical research and healthcare innovation in Qatar
